PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 217 filers reported holding PTC THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,373,459 | -42.7% | 596,763 | +4.1% | 0.00% | -42.9% |
| Q2 2023 | $23,323,228 | -13.8% | 573,475 | +2.7% | 0.01% | -12.5% |
| Q1 2023 | $27,044,488 | +26.5% | 558,309 | -0.3% | 0.01% | +14.3% |
| Q4 2022 | $21,374,627 | -22.2% | 559,985 | +2.3% | 0.01% | -30.0% |
| Q3 2022 | $27,484,000 | +29.8% | 547,488 | +3.6% | 0.01% | +42.9% |
| Q2 2022 | $21,174,000 | +10.8% | 528,538 | +3.2% | 0.01% | +16.7% |
| Q1 2022 | $19,117,000 | -3.9% | 512,380 | +2.6% | 0.01% | 0.0% |
| Q4 2021 | $19,883,000 | +9.4% | 499,179 | +2.2% | 0.01% | 0.0% |
| Q3 2021 | $18,182,000 | -12.7% | 488,610 | -0.9% | 0.01% | -14.3% |
| Q2 2021 | $20,836,000 | -7.0% | 492,908 | +4.2% | 0.01% | -12.5% |
| Q1 2021 | $22,395,000 | -18.6% | 472,965 | +4.9% | 0.01% | -27.3% |
| Q4 2020 | $27,525,000 | +32.9% | 451,001 | +1.8% | 0.01% | +10.0% |
| Q3 2020 | $20,714,000 | -5.1% | 443,077 | +3.0% | 0.01% | -9.1% |
| Q2 2020 | $21,821,000 | +27.7% | 430,045 | +12.2% | 0.01% | +10.0% |
| Q1 2020 | $17,093,000 | -5.1% | 383,152 | +2.1% | 0.01% | 0.0% |
| Q4 2019 | $18,017,000 | +51.1% | 375,114 | +6.4% | 0.01% | +42.9% |
| Q3 2019 | $11,924,000 | -18.3% | 352,548 | +8.8% | 0.01% | -22.2% |
| Q2 2019 | $14,587,000 | +8.4% | 324,137 | -9.3% | 0.01% | 0.0% |
| Q1 2019 | $13,454,000 | +22.9% | 357,431 | +12.1% | 0.01% | +12.5% |
| Q4 2018 | $10,947,000 | -17.7% | 318,944 | +12.8% | 0.01% | -11.1% |
| Q3 2018 | $13,295,000 | +33.3% | 282,854 | -4.3% | 0.01% | +28.6% |
| Q2 2018 | $9,972,000 | +65.0% | 295,635 | +32.4% | 0.01% | +40.0% |
| Q1 2018 | $6,044,000 | +92.2% | 223,327 | +18.5% | 0.01% | +150.0% |
| Q4 2017 | $3,144,000 | -12.1% | 188,488 | +5.4% | 0.00% | -33.3% |
| Q3 2017 | $3,578,000 | +26.4% | 178,795 | +15.8% | 0.00% | 0.0% |
| Q2 2017 | $2,831,000 | +128.7% | 154,429 | +22.8% | 0.00% | +200.0% |
| Q1 2017 | $1,238,000 | -4.6% | 125,761 | +5.8% | 0.00% | 0.0% |
| Q4 2016 | $1,298,000 | -17.8% | 118,921 | +5.5% | 0.00% | -50.0% |
| Q3 2016 | $1,580,000 | +280.7% | 112,761 | +91.1% | 0.00% | +100.0% |
| Q2 2016 | $415,000 | -36.2% | 59,021 | -41.4% | 0.00% | 0.0% |
| Q1 2016 | $650,000 | -80.8% | 100,786 | -3.6% | 0.00% | -80.0% |
| Q4 2015 | $3,388,000 | +29.8% | 104,549 | +7.0% | 0.01% | +25.0% |
| Q3 2015 | $2,610,000 | -35.7% | 97,721 | +16.0% | 0.00% | -33.3% |
| Q2 2015 | $4,056,000 | -2.6% | 84,252 | +23.1% | 0.01% | 0.0% |
| Q1 2015 | $4,164,000 | +22.8% | 68,428 | +4.5% | 0.01% | +20.0% |
| Q4 2014 | $3,391,000 | +32.0% | 65,498 | +12.2% | 0.01% | +25.0% |
| Q3 2014 | $2,569,000 | +95.5% | 58,353 | +16.1% | 0.00% | +100.0% |
| Q2 2014 | $1,314,000 | +44.4% | 50,260 | +44.5% | 0.00% | 0.0% |
| Q1 2014 | $910,000 | +160.0% | 34,786 | +68.9% | 0.00% | +100.0% |
| Q4 2013 | $350,000 | -21.7% | 20,591 | +3.2% | 0.00% | 0.0% |
| Q3 2013 | $447,000 | – | 19,943 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |